Abstract
In article number 2000802 by Xinhui Su, Xiaolian Sun, and co-workers, a 131I labeled ZnPc(COOH)4 conjugated ZnGa2O4:Cr3+ nanoplatform (131I-ZGCs-ZnPcC4) is developed for in vivo radiotherapy (RT) and radiation-induced photodynamic therapy (PDT). 131I can not only activate ZGCs for long-lasting luminescence which further continuously activates the photosensitizer for PDT, but also can directly kill cancerous cells. Combining self-activated PDT and RT, it is believed that the 131IZGCs- ZnPcC4 can greatly benefit deep tumor therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.